We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Illumina
ILMN
$33.6B
| $55.4M | 0.13% |
530,439
+441,292
| +495% | +$49.5M |
|
202
Advanced Drainage Systems
WMS
$9.59B
| $55.2M | 0.13% |
344,314
+4,240
| +1% | +$709K |
|
203
Owens Corning
OC
$10.2B
| $55M | 0.13% |
316,573
-66,487
| -17% | -$11.5M |
|
204
LKQ Corp
LKQ
$5.92B
| $54.8M | 0.13% |
1,317,672
+33,459
| +3% | +$1.5M |
|
205
Inspire Medical Systems
INSP
$2.16B
| $54.2M | 0.13% |
405,187
-48,013
| -11% | -$9.09M |
|
206
Advance Auto Parts
AAP
$2.62B
| $54M | 0.13% |
852,681
-7,024
| -0.8% | -$503K |
|
207
Cheniere Energy
LNG
$56B
| $53.8M | 0.13% |
307,821
-39,662
| -11% | -$6.31M |
|
208
Littelfuse
LFUS
$10B
| $53.7M | 0.13% |
209,976
+6,814
| +3% | +$1.69M |
|
209
Simpson Manufacturing
SSD
$7.09B
| $53.5M | 0.13% |
317,274
+2,392
| +0.8% | +$419K |
|
210
NextEra Energy
NEE
$169B
| $52.3M | 0.12% |
738,277
+85,843
| +13% | +$6.09M |
|
211
Natera
NTRA
$50.6B
| $52.1M | 0.12% |
480,745
+57,476
| +14% | +$5.84M |
|
212
Incyte
INCY
$24.7B
| $52M | 0.12% |
858,147
-77,223
| -8% | -$4.37M |
|
213
Motorola Solutions
MSI
$77.6B
| $51.9M | 0.12% |
134,318
+25,201
| +23% | +$9.09M |
|
214
Berkshire Hathaway Class B
BRK.B
$1.11T
| $51.6M | 0.12% |
126,795
-14,240
| -10% | -$5.82M |
|
215
Intellia Therapeutics
NTLA
$1.59B
| $51.5M | 0.12% |
2,300,889
+371,189
| +19% | +$8.84M |
|
|
SMAR
216
DELISTED
Smartsheet Inc.
SMAR
| $50.9M | 0.12% |
1,154,834
-584
| -0.1% | -$23.3K |
|
217
American Express
AXP
$219B
| $50.5M | 0.12% |
218,010
+170,316
| +357% | +$39.4M |
|
218
Martin Marietta Materials
MLM
$36B
| $50.4M | 0.12% |
93,072
+2,916
| +3% | +$1.69M |
|
219
Gaming and Leisure Properties
GLPI
$11.8B
| $50.1M | 0.12% |
1,109,215
-917
| -0.1% | -$40.5K |
|
220
On Holding
ONON
$8.94B
| $49.8M | 0.12% |
1,284,236
-29,379
| -2% | -$1.07M |
|
221
MoonLake Immunotherapeutics
MLTX
$1.04B
| $49.6M | 0.12% |
1,128,428
+28,672
| +3% | +$1.21M |
|
222
XPO
XPO
$20.9B
| $49.5M | 0.12% |
466,628
-400,471
| -46% | -$44.9M |
|
223
TransDigm Group
TDG
$60B
| $49.2M | 0.12% |
38,528
+1,179
| +3% | +$1.51M |
|
224
Netflix
NFLX
$324B
| $49.2M | 0.12% |
728,440
+218,580
| +43% | +$13.7M |
|
225
Dell
DELL
$346B
| $48.9M | 0.12% |
354,830
+221,676
| +166% | +$29.7M |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.